At Takeda Pharmaceuticals, a Data Scientist plays a pivotal role in bridging the gap between cutting-edge computational science and life-changing medicine. Takeda is a patient-focused, values-based, R&D-driven global biopharmaceutical leader. In this role, you will not simply build models in isolation; your work directly impacts clinical trial design, drug discovery, manufacturing optimization, and commercial strategy. By transforming complex biological, clinical, and operational data into actionable insights, you help accelerate the delivery of highly innovative medicines to patients worldwide.
Data science at Takeda is embedded across various business units, including Research & Development, Global Manufacturing & Supply, and commercial business units. Whether you are optimizing patient recruitment algorithms, analyzing real-world evidence (RWE) to understand disease progression, or building predictive maintenance models for plasma-derived therapies, your contribution has a direct line of sight to patient outcomes. The scale and complexity of genomic, clinical trial, and digital health data at present an intellectually stimulating environment for data scientists who want their technical expertise to serve a deep ethical purpose.
To succeed as a Data Scientist at Takeda, you must possess not only rigorous technical and mathematical capabilities but also a strong collaborative mindset. You will work alongside biologists, clinicians, epidemiologists, and product managers. This requires an ability to translate complex machine learning architectures into clear, business-oriented insights. Takeda values data scientists who are curious, scientifically minded, and deeply aligned with the company’s core values of integrity and patient-centricity.
Phone Screening
reportedData Scientist covers at least four different jobs: experimentation, product analytics, causal work on observational data, and applied modelling that ships into a system. A screening call is the cheapest place to find out which of them is being hired for, and doing that diagnosis openly reads as senior rather than fussy. Ask what the last few pieces of work on the team actually were, and roughly how a week splits between querying, modelling and stakeholder time. Then say which parts of that you have done and which you have not. Claiming the whole range is the fastest way to be caught one round later.
What to demonstrate
- Whether you can distinguish the flavours of the role and locate your own experience inside one of them honestly
- Whether you name what you have not done instead of stretching to cover every line of the posting
- Whether your hard constraints (notice period, location, work authorisation, level) surface now rather than at offer stage
How to prepare
- Map the last two years of your time into rough percentages across query writing, experiment design, modelling and stakeholder work, so a question about scope has a real answer
- Mark every responsibility in the posting as done, adjacent or new, and prepare one sentence for each adjacent item naming the closest thing you have actually built
- Decide which logistics are non-negotiable before the call so you can state them in one sentence rather than negotiating live
Technical Discussions
reportedA handful of shapes account for most of what gets asked in this format: a ranking or deduplication inside groups, a running or rolling total, a period-over-period comparison, and a cohort tracked forward over time. Recognising the shape quickly is most of the speed here; deriving it from scratch while a clock runs is where the time goes. Know that a window function keeps every row while a GROUP BY collapses them, and know which one the question needs. If the exercise is in Python instead of SQL, the same shapes arrive as groupby with transform, shift and merge, and the same grain mistakes are available.
What to demonstrate
- Whether you reach the right construct without a detour, such as ROW_NUMBER over a partition to deduplicate instead of a self-join against a MAX subquery
- Whether you know what your window frame actually is, since adding ORDER BY inside OVER changes the default frame and silently changes a running total
- Whether the thing runs. A near-miss that throws an error scores below a plainer query that returns the right rows.
How to prepare
- Write each of the four shapes once from memory against a small schema and keep the working version somewhere you will reread it: dedupe with ROW_NUMBER, a running total, a month-over-month change with LAG, and a retention table
- Compute one running total twice on data with tied timestamps, once on the default frame and once with ROWS BETWEEN UNBOUNDED PRECEDING AND CURRENT ROW, and look at where the two disagree
- If Python is on the table, rebuild the dedupe and the running total with groupby and cumsum, then assert the two implementations return identical rows
Take-Home Case Study
reportedBefore any modelling, the dataset is itself the first test. Take-home data usually carries something broken: rows duplicated at an unexpected grain, a join that silently drops part of the population, timestamps stored in more than one timezone, or missingness correlated with the outcome. An hour spent profiling row counts, key uniqueness and date ranges is not overhead, because it decides whether every number after it is real. What separates submissions is whether you report the defects you found and adapt the analysis to them, rather than modelling over them quietly and hoping the aggregate absorbs it.
What to demonstrate
- Whether you established the grain of each table and checked row counts after every join, and said so in the writeup
- Whether data defects you found are surfaced with their effect on the conclusion, instead of being dropped without comment
- Whether filters and exclusions are reproducible from the submitted code, with the size of the excluded population quantified
How to prepare
- Write a short profiling script you can point at any unfamiliar table: row count, distinct key count, null rate per column, and the min and max of every date field, then run it before anything else
- Write the funnel or the join chain as one query and check the row count at each grain, so a silent fan-out shows up as a number rather than as a wrong answer later
- On a past dataset, list every exclusion you applied and how many rows each one removed, then draft the single sentence about it you would put in a report
Panel Presentation
reportedWhere a loop ends with a senior leader, that conversation is rarely another skills test. The technical signal already exists by then, so the questions tend to open up: what you would look at first, where a metric you have heard about could mislead, what you would push back on. The decision being made is scope, which in practice means level and how much you would be trusted to own unsupervised. Treating it as a formality is the usual mistake. An open question late in the day is still being scored, and a vague answer reads as someone who has not run anything themselves.
What to demonstrate
- Whether your view of the business has anything specific behind it, given that you are working only from what is public and are expected to say so
- Whether the scope of work you describe owning matches the scope of the role, instead of sitting a level below it
- Whether you can disagree with something concrete and stay useful about it, rather than agreeing with everything said in the room
- Whether your questions are ones only this person could answer, as opposed to ones the recruiter already covered
How to prepare
- Build one view you could defend for two minutes using only public information: what the funnel probably looks like, which metric likely drives decisions, and where that metric could mislead. Being wrong for a stated reason survives this round; having no view does not
- Write down the largest piece of work you have owned from question to decision, who else touched it, and what you decided alone, then check that it reads at the level you are interviewing for
- Prepare one thing you would want changed if you joined and phrase it as a question rather than a verdict, so it opens a conversation instead of closing one
Behavioral Rounds
reportedMost of the weight in this round sits on the disagreement questions. Data work routinely produces an answer someone senior did not want, and the interviewer is trying to learn what you do in that hour. Both failure modes are common: folding as soon as a director pushes back, and treating the pushback as ignorance to be corrected with a better chart. A strong answer usually contains a specific thing the other person knew that you did not, and describes how you found out whether it changed the conclusion.
What to demonstrate
- Whether you can state the other side's argument accurately before you explain why you disagreed
- What you treated as evidence during the disagreement, such as a rerun under their assumption or a holdout check, rather than persuasion technique
- Whether you distinguish being overruled from being wrong, and can give an example of each
How to prepare
- Write out one disagreement where you turned out to be wrong, and say what in the data misled you. Candidates prepare the story where they were right, and the follow-up asks for the other one.
- For your main disagreement story, be ready to say what result would have made you drop your position. If no such result exists, you were not arguing from the data.
- Practise stating the opposing position out loud in one sentence the stakeholder would accept, then continue the story.
PracHub editorial advice for the preparation topics above.
Reading the most recent months of a claims-based series as real
Claims incur before they are reported and paid, so recent incurred months are systematically undercounted until runout completes. The lag is not uniform: pharmacy adjudicates in days, professional claims in weeks, inpatient facility claims in months. That means recent data is both too low and mix-shifted toward cheap services, which reads as a cost improvement and a utilisation drop at once. The fix is to hold the last three incurred months back or apply completion factors, and to state the paid-through date on every chart.
Immortal time in adherence, treatment, and enrolment definitions
Classifying members as adherent, treated, or programme-enrolled requires them to survive and stay covered long enough to accumulate the defining events. That guaranteed event-free interval is assigned to the exposed group, so the exposure looks protective for reasons that have nothing to do with the treatment. Adherence studies are the classic case: measuring 12-month proportion of days covered and then comparing mortality builds survival into the exposure definition. Use time-varying exposure or a landmark analysis with the classification window excluded from follow-up.
Reporting a mean for a heavy-tailed metric without saying what it hides
For spend, session length or items per order, a small fraction of units carries most of the total, so the mean has a wide standard error and one account can move it. Fix the handling before you see the result: cap or winsorise at a pre-declared percentile, and report the median or the share above a threshold next to the mean. Capping changes the estimand, so say which question the capped number answers, and check how much of any difference comes from the top 0.1 percent of units.
Averaging per-user rates to produce a population rate
Decide which quantity you want: the mean of per-user ratios and the ratio of summed numerator to summed denominator are different estimands, and heavy users dominate one but not the other. For a ratio metric, aggregate numerator and denominator separately and use the delta method for its variance.
Choose a category, try a prompt, then open its approach, worked solution or follow-up when you need it.
Describe the difference between parametric and non-parametric statisti…
Describe the difference between parametric and non-parametric statistical tests. When would you use a Mann-Whitney U test over a t-test?
Approach
- Sanity-check the answer against a simple bound or a simulated case.
- Quantify uncertainty explicitly rather than reporting a point estimate alone.
- Write down the assumption the method needs before you use the method.
Follow-up
- How would you explain this result to someone who does not know statistics?
- What sample size would you need to detect an effect half this size?
Explain how you would set up a Monte Carlo simulation to predict clini…
Explain how you would set up a Monte Carlo simulation to predict clinical trial enrollment timelines.
Approach
- Say what the estimate is of, and over what population it generalises.
- Translate the result into the decision it informs, in one plain sentence.
- Quantify uncertainty explicitly rather than reporting a point estimate alone.
Follow-up
- What sample size would you need to detect an effect half this size?
- Which assumption here is most likely to be violated in practice?
What probability distribution would you use to model patient arrivals …
What probability distribution would you use to model patient arrivals at a clinical site, and why?
Approach
- Say what the estimate is of, and over what population it generalises.
- Write down the assumption the method needs before you use the method.
- Translate the result into the decision it informs, in one plain sentence.
Follow-up
- What sample size would you need to detect an effect half this size?
- Which assumption here is most likely to be violated in practice?
Explain the mathematical difference between L1 (Lasso) and L2 (Ridge) …
Explain the mathematical difference between L1 (Lasso) and L2 (Ridge) regularization. When would you choose one over the other?
Approach
- Pick an evaluation metric that matches the cost of each error type, not a default.
- Check what information would not exist at prediction time, and exclude it.
- Set a baseline first, so any model has something honest to beat.
Follow-up
- How would you choose the decision threshold, and who owns that choice?
- Where could label leakage enter this setup?
What are the assumptions of a linear regression model, and how do you …
What are the assumptions of a linear regression model, and how do you test for them?
Approach
- Frame the prediction: the label, the moment of prediction, and the action it triggers.
- Say how the offline result would be validated online before it is trusted.
- Pick an evaluation metric that matches the cost of each error type, not a default.
Follow-up
- What would you monitor after launch to know the model is still valid?
- How would you choose the decision threshold, and who owns that choice?
Collapse claim versions before summing allowed amounts by member
You are given medical_claim_line as a pandas DataFrame: claim_line_id, claim_id, claim_version, frequency_code (1 original, 7 replacement, 8 void), member_id, service_start_date, procedure_code, allowed_amount, claim_status. Return total allowed_amount per member for service dates in one stated calendar month, counting each claim once at its surviving version and excluding any claim whose surviving version is a void. Multi-line claims must keep every line of that surviving version. Output columns: member_id, allowed_amount, sorted descending. Do not deduplicate on claim_id alone.
Approach
- Separate the two grains out loud before writing code: versions live at the claim level, dollars live at the line level. Every bug in this exercise comes from mixing them.
- Compute the surviving version per claim with a groupby transform of max over claim_version, then keep the lines whose claim_version equals that value. A transform keeps the frame at line grain, which a sort plus head(1) does not.
- Drop whole claims whose surviving version carries frequency_code 8. A void is not a zero-dollar line, it retracts the claim, so filtering rows rather than claims leaves the prior version's lines behind.
- Filter to claim_status 'paid' and state the assumption: denied, pended and reversed lines carry an allowed_amount that never became a liability, so including them overstates cost.
- Restrict service_start_date to the month boundaries, then groupby member_id and sum. Sort descending and return.
Worked solution 20 min
- Build a max-version lookup per claim_id with groupby('claim_id')['claim_version'].transform('max') and keep rows where claim_version equals it.
- From the surviving rows, collect the claim_ids whose frequency_code is 8 and drop those claim_ids entirely.
- Filter claim_status to 'paid' and service_start_date into the month window.
- Group by member_id, sum allowed_amount, sort descending, reset the index.
Follow-up
- A claim has versions 1, 7, 7 where the second replacement has fewer lines than the first. What does your code return and is that correct?
- How would you handle a claim whose lines span two calendar months at the boundary of the reporting window?
- The same logic has to run over 400 million lines in a warehouse. What changes, and what stays the same?
Find inpatient encounters with no resulted lab during the stay
encounter holds encounter_id, patient_id, encounter_type, admit_ts, discharge_ts and facility_id. lab_result holds result_id, order_id, patient_id, encounter_id (NULL for outpatient standing orders), loinc_code, specimen_collected_ts, resulted_ts and result_status. Return every inpatient encounter discharged in 2025 with no final or corrected lab_result linked to it. A colleague wrote WHERE encounter_id NOT IN (SELECT encounter_id FROM lab_result) and got zero rows back. Say why, write the correct query, then say what changes when labs must instead be matched on patient_id with the specimen collected between admit_ts and discharge_ts.
Approach
- Name the mechanism rather than the symptom. x NOT IN (subquery) expands to x <> y1 AND x <> y2 AND ..., and a single NULL y makes that chain UNKNOWN, never TRUE. Since lab_result.encounter_id is nullable by design for standing orders, this query can only ever return zero rows.
- Rewrite as NOT EXISTS, or LEFT JOIN with an IS NULL filter. Both treat a NULL key as no match rather than as unknown. Adding IS NOT NULL inside the NOT IN subquery also works, but NOT EXISTS is the habit that survives someone making another column nullable later.
- Put the result_status predicate inside the correlated subquery or the ON clause, not in an outer WHERE. Outside, it turns the anti-join back into an inner join and an encounter whose only labs were cancelled disappears instead of qualifying.
- For the timestamp variant, match on patient_id with specimen_collected_ts inside the stay rather than resulted_ts. A specimen drawn an hour before discharge can result the next day, and anchoring on resulted_ts would wrongly call that stay lab-free.
- Restrict to encounter_type 'inpatient' and discharge_ts in 2025, and report open encounters with a NULL discharge_ts as a separate count instead of letting the filter swallow them.
Follow-up
- Write the LEFT JOIN form and say exactly where the result_status predicate must sit for the two forms to agree.
- How would you separate encounters whose only labs were cancelled from encounters with no lab rows at all?
- Some encounters carry member_id NULL because the person index did not match. What does that do to a payer-side version of this measure?
Turn overlapping coverage spans into fractional member-month denominators
member_enrollment holds span_id, member_id, plan_id, product_type, effective_date and termination_date, which is NULL while the span is active. A member can hold several spans in a year, and back-dated plan changes make spans overlap. Return one row per calendar month of 2025 with total member-months, where a member contributes covered days in the month divided by that month's length, and a day covered by two overlapping spans counts once. Both span endpoints are inclusive. Collapse overlaps with window functions before joining a month calendar, and do not assume one span per member.
Approach
- Normalise the open end first. COALESCE(termination_date, DATE '9999-12-31') or clip to the reporting end, because a NULL termination_date makes every BETWEEN comparison unknown and drops exactly the members who are still covered.
- Merge overlapping spans per member before the calendar join. Order by effective_date, carry a running MAX of prior termination_date with a frame ending one row before, and open a new island where effective_date exceeds that running max plus one day, which keeps adjacent spans contiguous rather than splitting them.
- Clip each merged island to the reporting year, then cross join to a twelve-row month calendar and keep pairs that intersect.
- Compute covered days as LEAST(island_end, month_end) minus GREATEST(island_start, month_start) plus one, and divide by the actual length of that month rather than a flat 30, so February and the 31-day months are not distorted.
- Sum the fractions by month. Merging after the calendar join also works but forces a DISTINCT over member-days, which stops scaling at population size.
Worked solution 30 min
- CTE bounded: clip spans to 2025-01-01 through 2025-12-31 with COALESCE on termination_date, discarding spans that do not intersect the year.
- CTE merged: gaps-and-islands per member using LAG and a running MAX over preceding rows to collapse overlapping and adjacent spans.
- CTE months: twelve rows of month_start, month_end and days_in_month.
- Join merged to months on interval intersection and compute covered_days per pair.
- SUM(covered_days / days_in_month::numeric) grouped by month, ordered by month.
Follow-up
- Where does a continuous-enrolment filter with an allowable 45-day gap belong, and how does that change the island boundary rule?
- One human appears under two member_ids after a master person index merge. What does that do to member-months, and how would you detect it?
- How do you treat a span that terminates on the day it starts, and what does that row usually represent?
How do you determine the required sample size for an A/B test or a cli…
How do you determine the required sample size for an A/B test or a clinical study to achieve statistical power?
Approach
- Decide the analysis before seeing data, including how long it runs and when you look.
- Say whether units interfere with each other, and switch design if they do.
- Name the randomisation unit first; it decides the variance and what the test can detect.
Follow-up
- How would you handle interference between treated and control units?
- What would you do if you could not randomise at all?
Decompose risk-adjusted cost per member into owned leaf metrics
Build a metric tree, at most four levels deep, from risk-adjusted allowed PMPM down to leaves an owner can move. Data: medical_claim_line (allowed_amount, units, procedure_code, place_of_service_code, service_start_date, claim_version, frequency_code), pharmacy_claim (allowed_amount, days_supply, is_generic, formulary_tier, reversal_flag), member_enrollment (coverage spans, prospective_risk_score). Give the arithmetic identity each split rests on, the leading indicator at each leaf, and identify the one node where the arithmetic is exact but the attribution is not.
Approach
- State the base identity before drawing anything. Allowed PMPM equals total allowed over member-months, and it decomposes exactly by service category c as the sum over c of (units_c / member-months) times (allowed_c / units_c). Utilization per member-month and allowed per unit, summed across categories, so category mix is inside the sum rather than a separate hand-wave.
- Give the change decomposition too, because the tree will be read on deltas: the change in PMPM equals the sum over categories of (change in utilization times base price) plus (base utilization times change in price) plus (change in utilization times change in price). The third term is the interaction, it is not noise, and an analysis that drops it will not reconcile.
- Build the medical branch to leaves with owners: inpatient admits per 1,000 member-months and allowed per admit (with DRG case mix as the sub-split), ambulatory visits per 1,000 and allowed per visit split by place_of_service_code, and emergency visits per 1,000 and allowed per visit. Prepare the data with version dedup to the surviving claim_version before a single dollar is summed, since frequency_code 7 replaces and 8 voids.
- Build the pharmacy branch on 30-day equivalents: scripts_30 equals the sum of days_supply over 30 on unreversed fills, so pharmacy PMPM equals (scripts_30 per member-month) times (allowed per 30-day script). Split the price term exactly as g times the generic price plus (1 minus g) times the brand price, where g is the generic dispensing rate, which makes generic substitution and unit price separable leaves with different owners.
- Attach one leading indicator per leaf: prior-authorization approvals and elective surgical bookings ahead of inpatient admits, contract effective dates ahead of allowed per unit, site-of-service steering ahead of the ambulatory place_of_service mix, new-to-brand starts and formulary tier placement ahead of pharmacy price.
- Name the node where arithmetic is exact but attribution is not: the risk-adjustment denominator. Dividing by the population mean prospective_risk_score is exact arithmetic, but the score is built from coded diagnoses, so more complete coding raises the denominator and lowers risk-adjusted PMPM with no change in care delivered. Carry raw PMPM, the mean risk score trend and a coding-intensity measure such as diagnoses per member-year beside it, permanently.
Worked solution 45 min
- Write the base identity and the three-term change decomposition on paper first, and confirm the terms sum to the total change on a two-category toy example before touching real data.
- Specify the preparation rules that precede any aggregation: dedup medical_claim_line to the surviving version per claim_id using claim_version and frequency_code, drop both rows of every reversed pharmacy pair, and build member-months from coverage spans with partial months counted fractionally.
- Draw the medical branch and the pharmacy branch to leaf level, writing the identity beneath each split rather than only the metric name.
- Write the generic-dispensing split as the exact price identity and confirm it reproduces the observed allowed per 30-day script.
- Attach one leading indicator and one named owning function to each leaf.
- Write the caveat on the risk-adjustment node, including the two companion series that must be published with it.
Follow-up
- Utilization is flat and allowed per unit is flat, yet PMPM rose 4 percent. Name every place the increase can be hiding.
- Your member-month denominator came from coverage spans that overlap across products for some members. What does that do to PMPM, and how do you decide whether to deduplicate?
- Which leaf would you refuse to put on a team's scorecard, and why?
First-pass denial rate doubled in one received week
First-pass denial rate jumped from 6.1 to 11.8 percent in a single received_date week and stayed at the new level. Nothing in the adjudication rules changed that week. You have medical_claim_line: claim_id, claim_version, frequency_code, claim_status, denial_reason_code, member_id, received_date, adjudicated_at, billing_provider_npi. The metric counts lines whose first adjudication returns 'denied', over lines received in the window at claim_version = 1. Find the cause, say whether denial behaviour actually changed, and deliver the corrected series plus the query change that fixes it.
Approach
- Cut the excess by denial_reason_code before anything else. A behaviour change spreads across codes; an upstream failure concentrates in one. If a single eligibility-related code carries nearly all of the 5.7 point excess, the claims are fine and the eligibility data was not.
- Join the denied lines to member_enrollment and compare the span's created_at to the claim's received_date. Lines denied for members whose coverage span loaded after the claim arrived are a load-ordering failure, not a coding failure.
- Check resolution downstream: take those claim_ids and look for a later version with frequency_code 7 that adjudicates to 'paid'. A high resubmit-and-pay share confirms the denial was transient and recoverable.
- Verify the denominator is not the mover. Count lines at claim_version = 1 by received_date and check the weekday mix, because submission batching makes received_date strongly day-of-week patterned and a short or holiday week shifts the denominator without changing behaviour.
- Confirm runout: the metric should be held until 60 days of adjudication have passed, so check that the comparison weeks are equally mature rather than comparing a settled week to a fresh one.
- Restate the series with the affected reason code broken out as its own line, and change the query to carry denial_reason_code into the reported breakdown rather than only the headline rate.
Follow-up
- The affected lines all get paid on resubmission. Is the first-pass denial rate then wrong, or right and uninteresting?
- How would you monitor for this class of failure without waiting for someone to notice a chart?
- What changes if the excess is spread evenly across denial_reason_code instead of concentrated?
For a candidate whose interviews will centre on A/B testing, metric movement and causal claims. Design comes before arithmetic, arithmetic before analysis, and the week ends by rehearsing the readout rather than the derivation.
Prepare, practise & reflect
One practical outcome each day. Spend longer where you need it.
0 / 7 done01Design one test end to end on paper
- Take a single feature change and write the full design: randomization unit, the exact point of exposure, the primary metric with its grain, guardrails, allocation, planned duration, and the decision rule committed before any data exists.
- Write why the randomization unit must sit at or above the level where treatment can spill over, and give one case where user-level randomization is still contaminated (shared accounts or devices, or two participants in the same marketplace).
- State in advance what you will do if the primary metric is flat while a secondary metric is significant.
Deliverable: A one-page test design with a decision rule written before launch.
Practice prompt ↗Practice prompt ↗Worked solution ↗02Power arithmetic until it is automatic
- Compute required sample size per arm for a binary metric with the normal approximation, n is approximately 2 times (z for alpha/2 plus z for power) squared times p(1 minus p) divided by delta squared, for baselines of 2, 10 and 40 percent at a 5 percent relative lift, and note that for a fixed relative lift the requirement falls as the baseline rises because delta grows proportionally with p.
- Redo the calculation for a continuous metric using variance in place of p(1 minus p), and show why a heavy-tailed quantity such as revenue per user needs either far more traffic or a capped version with a stated cap.
- Convert one of the results into weeks given a weekly eligible traffic figure, then list the two honest ways to shorten it (accept a larger detectable effect, or reduce variance) and write why quietly lowering the power target is a decision to miss more real wins, not a speedup.
Deliverable: A small script or sheet that maps baseline, minimum detectable effect, alpha and power to sample size and weeks, cross-checked against a published calculator.
Practice prompt ↗Practice prompt ↗03Variance and the unit-of-analysis problem
- Take a ratio metric whose denominator is not the randomization unit (clicks per session, randomized by user) and compute the standard error twice, once naively at session level and once by the delta method or a user-level bootstrap, then record how much the naive version understates it.
- Implement CUPED on simulated data: choose a pre-period covariate X measured before assignment, estimate theta as Cov(Y, X) divided by Var(X), and analyse Y minus theta times (X minus its mean) in place of Y. Confirm the variance of the adjusted outcome equals the raw variance multiplied by one minus the squared correlation between Y and X, so a correlation of 0.45 removes about 20 percent of the variance and not 80.
- Now run that simulation a few hundred times and confirm the adjusted effect estimate is unbiased for the same effect rather than numerically identical to the raw one. Within any single run the two differ, sometimes by a large fraction of the true effect, because the two arms' pre-period covariate means never coincide exactly in a finite sample; they agree in expectation, which is the property that matters and the one to state out loud.
Deliverable: A notebook showing the adjusted estimator with a measurably smaller variance than the raw one, plus a repeated-simulation table showing the two estimators agreeing on average while differing run by run.
Practice prompt ↗Practice prompt ↗04Validity threats you can actually test for
- Run a sample ratio mismatch check as a chi-square goodness-of-fit test against the intended allocation, and write the three causes you would chase first (assignment logged before exposure, an arm-specific redirect or load failure, bot filtering applied asymmetrically).
- Simulate peeking: generate A/A data, test daily at alpha 0.05 across 14 looks, record the inflated false positive rate, then apply an alpha-spending boundary or commit to a fixed horizon and confirm the rate returns to nominal.
- Write how you would separate a novelty effect from a durable lift using the treatment effect plotted against days since first exposure, and what shape would change your recommendation.
Deliverable: One table showing the peeking false positive rate before and after correction, plus a written SRM triage list.
Practice prompt ↗Practice prompt ↗Worked solution ↗05When randomization is not available
- Write the identifying assumption for difference-in-differences (parallel trends in the absence of treatment), then plot pre-period trends for two candidate control groups and justify rejecting one of them.
- Design a switchback test for a change where user-level randomization would leak across participants, choosing a time-block length against the carryover you expect and saying how you would detect carryover in the data.
- List what an interrupted time series or a synthetic control buys you and the one thing neither can rule out: an unobserved shock that coincides with the launch.
Deliverable: A one-page memo recommending a single quasi-experimental design and naming its weakest assumption explicitly.
Practice prompt ↗Practice prompt ↗06The readout query
- Write the assignment-to-exposure join that returns exactly one row per unit per experiment, and handle units appearing in both arms by excluding and counting them rather than silently keeping one.
- Compute the per-arm metric, its variance and the relative lift with a confidence interval in SQL, then reproduce the identical numbers in a notebook as a cross-check.
- Add a segment breakdown and write the sentence that keeps it from being p-hacking: segments declared in advance, everything else reported as exploratory and corrected for multiplicity.
Deliverable: A single query that outputs the full readout table, matched to a notebook recomputation.
Practice prompt ↗Practice prompt ↗07Present it to someone who will not read the appendix
- Give a 10-minute readout of a real or simulated experiment in the order decision, number, uncertainty, caveat.
- Have your listener ask "can we ship it" in the case where the primary is flat and a guardrail moved, and answer with a recommendation rather than a request for more data.
- Rewrite your opening line so the recommendation lands before any methodology.
Deliverable: A one-page readout whose first line is the recommendation.
Practice prompt ↗Practice prompt ↗Worked solution ↗Expand any day for tasks and deliverables. Your progress is saved on this device.
Half of this section is about translation. Be ready to describe how you explained a result to someone who did not want the method, only the implication, and what you did when the simplified version started being repeated in a way that overstated it. Correcting your own simplification is a strong beat.
If you are simulating clinical trial outcomes, how do you handle covar…
If you are simulating clinical trial outcomes, how do you handle covariate shift or missing data in your simulation design?
Approach
- State the situation in two sentences and spend the rest on your reasoning.
- Quantify the outcome, including what you would not claim credit for.
- Pick a story where you drove the decision, not one where you observed it.
Follow-up
- What would you do differently if you ran that project again?
- What did you decide not to do, and why?
How do you handle highly imbalanced datasets, particularly in clinical…
How do you handle highly imbalanced datasets, particularly in clinical or diagnostic use cases where the positive class is extremely rare?
Approach
- Name the disagreement or constraint, and how you resolved it with evidence.
- State the situation in two sentences and spend the rest on your reasoning.
- Quantify the outcome, including what you would not claim credit for.
Follow-up
- How did you know the outcome was caused by your change?
- What would you do differently if you ran that project again?
Push back on an over-broad extract without blocking the work
A researcher asks for a one-off extract covering 12,000 members: member_id, date of birth, five-digit residential postal code, full lab_result rows including value_text, and clinical note text, held on their laptop for a retrospective analysis of one lab analyte over time. They describe it as de-identified because names are excluded. A flat refusal is not an acceptable answer. Deliverable: the column list you will actually provide with a justification per retained field, the sentence explaining why free text defeats an enumerated-identifier approach, your small-cell rule for the published stratification, and what you deliver this week.
Approach
- The probe is whether privacy is a design skill for you or a compliance reflex. Flat refusal and unquestioned fulfilment both fail, for opposite reasons.
- Reconstruct the analysis from the research question rather than from the request. A longitudinal trend in one analyte needs a stable pseudonymous subject key, the analyte's loinc_code, value_numeric, units, the reference bounds, and a date. It does not need names, notes, or a precise birth date.
- Replace each identifier with the least precise version that still answers the question: a salted per-study pseudonym instead of member_id, age in years or an age band instead of date of birth, a consistent per-subject date offset if only intervals matter, and a coarser geography than five-digit postal code.
- Explain the free-text problem in one sentence. Removing an enumerated list of identifier fields does not de-identify a note, because notes carry names, relationships, employers, dates and rare clinical detail in prose, so only a reviewed extraction into structured fields or a formal statistical determination addresses it.
- Set the publication rule before the analysis runs. Suppress cells below a stated threshold and suppress complements too, because a reader holding a row total and all but one cell recovers the suppressed count by subtraction.
- Keep them moving. Deliver the reduced extract into a controlled environment this week rather than onto a laptop, and offer to derive any note-based variable yourself as a structured flag so they never need the prose.
Follow-up
- They say the age band loses resolution their model needs. What do you do?
- How do you set the suppression threshold, and who signs off on it?
- The analysis later needs linking to a second data source. What changes?
- 01
If you are simulating clinical trial outcomes, how do you handle covariate shift or missing data in your simulation design?
- 02
How do you handle highly imbalanced datasets, particularly in clinical or diagnostic use cases where the positive class is extremely rare?
- 03
A researcher asks for a one-off extract covering 12,000 members: member_id, date of birth, five-digit residential postal code, full lab_result rows including value_text, and clinical note text, held on their laptop for a retrospective analysis of one lab analyte over time. They describe it as de-identified because names are excluded. A flat refusal is not an acceptable answer. Deliverable: the column list you will actually provide with a justification per retained field, the sentence explaining why free text defeats an enumerated-identifier approach, your small-cell rule for the published stratification, and what you deliver this week.
Is this an official Takeda Pharmaceuticals interview guide?
No. It is PracHub's own research and practice material for the Data Scientist role at Takeda Pharmaceuticals. Rounds and questions reflect what candidates have reported, not a process Takeda Pharmaceuticals has published, and they change over time. Confirm the current format and scope with your recruiter.
PracHub interview research ↗How difficult is the Data Scientist interview process at Takeda?
The interview process is generally rated as average to difficult. While some candidates find the technical questions straightforward, the rigor comes from the combination of a take-home case study, deep technical probing of your past projects, and an intense focus on behavioral alignment and ethical values.
PracHub interview research ↗What is the typical timeline from the initial application to an offer?
The timeline typically ranges from 3 to 6 weeks. This includes the initial recruiter call, scheduling technical rounds, completing and presenting the case study, and final behavioral interviews. The company is structured but can sometimes experience delays depending on internal team availability.
PracHub interview research ↗How important are Takeda's corporate values during the interview?
They are absolutely critical. Takeda is a values-driven organization. Multiple candidates have reported that failing to show alignment with Takedaism (Integrity, Fairness, Honesty, Perseverance) or failing to prioritize the patient in hypothetical scenarios led to rejection, even with strong technical performances.
PracHub interview research ↗Is a background in biology or pharmaceuticals required?
While prior experience in life sciences or healthcare is a significant advantage, it is not a strict requirement for all teams. If you have strong quantitative skills, a passion for the mission, and a proven ability to learn complex domains quickly, you can be highly competitive.
PracHub interview research ↗Sources & methodology 3 sources ↗
No official company page is cited. Rounds and questions come from candidate reports and PracHub editorial material; each source shows the date it was read.
- 01PracHub interview research ↗
PracHub editorial research into this company and role, maintained with this guide. Candidate-reported, not an employer publication.
PracHub page · Accessed 2026-09-22 - 02PracHub Data Scientist practice ↗
Cross-company practice questions for this role.
PracHub page · Accessed 2026-09-22 - 03PracHub interview preparation framework ↗
The framework the preparation plan follows.
PracHub page · Accessed 2026-09-22
Explore related engineering environments and compare the preparation focus.
Veracyte Data Scientist Interview Questions & Guide 2026
Causal-inference exercises for Veracyte data scientist prep: difference-in-differences, matching, instrumental variables, and knowing when observational data simply cannot answer the question asked.
Zoetis Data Scientist Interview Questions & Guide 2026
Metric-diagnosis practice for Zoetis data scientist candidates: a number moves week over week and you work out why, splitting by segment, ruling out a logging or release change, and separating a mix shift from a real change in user behaviou
Vizient Data Scientist Interview Questions & Guide 2026
Communication practice for Vizient data scientist candidates: turn an analysis into a recommendation, name the uncertainty honestly, and answer the follow-up a skeptical stakeholder will raise.
Vibrant Emotional Health Data Scientist Interview Questions & Guide 2026
Case practice for the Vibrant Emotional Health data scientist interview, where the prompt is deliberately underspecified and your first move is scoping it into something measurable.